Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Allergy diagnostics and therapeutics Market, by Region, 2020-2030 (USD Billion)
1.2.2. Allergy diagnostics and therapeutics Market, by Product, 2020-2030 (USD Billion)
1.2.3. Allergy diagnostics and therapeutics Market, by Allergen Type, 2020-2030 (USD Billion)
1.2.4. Allergy diagnostics and therapeutics Market, by Test type, 2020-2030 (USD Billion)
1.2.5. Allergy diagnostics and therapeutics Market, by Drug Class, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Allergy diagnostics and therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Allergy diagnostics and therapeutics Market Dynamics
3.1. Allergy diagnostics and therapeutics Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of allergies
3.1.1.2. Advancements in technology and launch of new products
3.1.2. Market Challenges
3.1.2.1. Low adoption and penetration in developing countries due to the high cost of technology
3.1.2.2. Lack of allergen standardization
3.1.3. Market Opportunities
3.1.3.1. High adoption of immunotherapy drugs
3.1.3.2. Rising exposure to environmental pollutants
Chapter 4. Global Allergy diagnostics and therapeutics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Allergy diagnostics and therapeutics Market, by Product
5.1. Market Snapshot
5.2. Global Allergy diagnostics and therapeutics Market by Product, Performance – Potential Analysis
5.3. Global Allergy diagnostics and therapeutics Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
5.4. Allergy diagnostics and therapeutics Market, Sub Segment Analysis
5.4.1. Instruments
5.4.2. Consumables
5.4.3. Services
Chapter 6. Global Allergy diagnostics and therapeutics Market, by Allergen Type
6.1. Market Snapshot
6.2. Global Allergy diagnostics and therapeutics Market by Allergen Type, Performance – Potential Analysis
6.3. Global Allergy diagnostics and therapeutics Market Estimates & Forecasts by Allergen Type 2020-2030 (USD Billion)
6.4. Allergy diagnostics and therapeutics Market, Sub Segment Analysis
6.4.1. Food
6.4.2. Inhaled
6.4.3. Drugs
6.4.4. Others
Chapter 7. Global Allergy diagnostics and therapeutics Market, by Test type
7.1. Market Snapshot
7.2. Global Allergy diagnostics and therapeutics Market by Test type, Performance – Potential Analysis
7.3. Global Allergy diagnostics and therapeutics Market Estimates & Forecasts by Test type 2020-2030 (USD Billion)
7.4. Allergy diagnostics and therapeutics Market, Sub Segment Analysis
7.4.1. In Vivo test
7.4.2. In vitro test
Chapter 8. Global Allergy diagnostics and therapeutics Market, by Drug Class
8.1. Market Snapshot
8.2. Global Allergy diagnostics and therapeutics Market by Drug Class, Performance – Potential Analysis
8.3. Global Allergy diagnostics and therapeutics Market Estimates & Forecasts by Drug Class 2020-2030 (USD Billion)
8.4. Allergy diagnostics and therapeutics Market, Sub Segment Analysis
8.4.1. Antihistamines
8.4.2. Decongestants
8.4.3. Corticosteroids
8.4.4. Mast Cell Stabilizers
8.4.5. Leukotriene Inhibitors
8.4.6. Nasal Anti-cholinergic
8.4.7. Others
Chapter 9. Global Allergy diagnostics and therapeutics Market, Regional Analysis
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Allergy diagnostics and therapeutics Market, Regional Market Snapshot
9.4. North America Allergy diagnostics and therapeutics Market
9.4.1. U.S. Allergy diagnostics and therapeutics Market
9.4.1.1. Product breakdown estimates & forecasts, 2020-2030
9.4.1.2. Allergen Type breakdown estimates & forecasts, 2020-2030
9.4.1.3. Test type breakdown estimates & forecasts, 2020-2030
9.4.1.4. Drug Class breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Allergy diagnostics and therapeutics Market
9.5. Europe Allergy diagnostics and therapeutics Market Snapshot
9.5.1. U.K. Allergy diagnostics and therapeutics Market
9.5.2. Germany Allergy diagnostics and therapeutics Market
9.5.3. France Allergy diagnostics and therapeutics Market
9.5.4. Spain Allergy diagnostics and therapeutics Market
9.5.5. Italy Allergy diagnostics and therapeutics Market
9.5.6. Rest of Europe Allergy diagnostics and therapeutics Market
9.6. Asia-Pacific Allergy diagnostics and therapeutics Market Snapshot
9.6.1. China Allergy diagnostics and therapeutics Market
9.6.2. India Allergy diagnostics and therapeutics Market
9.6.3. Japan Allergy diagnostics and therapeutics Market
9.6.4. Australia Allergy diagnostics and therapeutics Market
9.6.5. South Korea Allergy diagnostics and therapeutics Market
9.6.6. Rest of Asia Pacific Allergy diagnostics and therapeutics Market
9.7. Latin America Allergy diagnostics and therapeutics Market Snapshot
9.7.1. Brazil Allergy diagnostics and therapeutics Market
9.7.2. Mexico Allergy diagnostics and therapeutics Market
9.8. Middle East & Africa Allergy diagnostics and therapeutics Market
9.8.1. Saudi Arabia Allergy diagnostics and therapeutics Market
9.8.2. South Africa Allergy diagnostics and therapeutics Market
9.8.3. Rest of Middle East & Africa Allergy diagnostics and therapeutics Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Company 1
10.1.2. Company 2
10.1.3. Company 3
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. R-Biopharm AG
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Recent Developments
10.3.2. EUROIMMUN Medizinische Labordiagnostika AG
10.3.3. DASIT Group SPA
10.3.4. AESKU.GROUP GmbH
10.3.5. bioMérieux SPA
10.3.6. Danaher Corporation
10.3.7. Thermo Fisher Scientific, Inc
10.3.8. Stallergenes Greer
10.3.9. Minaris Medical America, Inc.
10.3.10. Siemens Healthcare GmbH
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/